NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cyto-Facto Inc.

Cyto-Facto Inc.

Private
KobeHealthcare & Life Scienceshttps://www.cytofacto.com/en/

Last Round

Series B

Jun 13, 2025

Total Funding Raised

$18M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cyto-Facto Inc. is a biotechnology company that provides contract development and manufacturing (CDMO) services for gene and cell therapy solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Vertical SaaS, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

cell and gene therapyCDMOcontract manufacturingCGTGMP manufacturingmanufacturing execution systemMESprocess developmentbiotech manufacturingquality control testingGxP compliancevertical SaaSpharma techdigital manufacturinglab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cyto-Facto Inc. Comps

Public and private peers based on sector, stage, and business model.

Cyto-Facto Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cyto-Facto Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 13, 2025
Series AApr 22, 2024
SeedAug 28, 2023

Cyto-Facto Inc. Investors

Notable investors and investment history

Cyto-Facto Inc. investors
InvestorRounds
Kobe University CapitalSeries A
Mizuho CapitalSeries A
MPower PartnersSeries B, Series A
Sumitomo CorporationSeries B
Mitsubishi CorporationSeries A
SMBC Venture CapitalSeries A
Fujifilm CorporationSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 104% MoM, reaching 4.7K.

Cyto-Facto Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cyto-Facto Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cyto-Facto Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKobe
Employee Range6
Year Founded2023
Last FundingJun 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.